Skip to main content

Canadian Proteomics Firm Geneka to Open Base in France

NEW YORK, Nov. 13 — Geneka Biotechnology will be opening an office in Strasbourg, France, toward the start of the new year, the company announced on Tuesday. 

The new office, which represents the company’s first international expansion, will be small at first and will have no associated lab space, said Jean Rousseau, director of international marketing and sales at Montreal-based Geneka. 

The company chose Strasbourg for its central location and proximity to Germany, Switzerland, and the Alsace region in western France, where a lot of important research into transcription factors is carried out, added Rousseau. 

“The concentration of the market is there for us,” he said. 

Geneka, which focuses on proteomic regulators, including transcription factors, co-activators, co-repressors, and chromatin associated proteins, will be recruiting locally to fill the new office.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.